67 phenotypes from 6 alleles in 9 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Kat6atm1.1Glac/Kat6a+ involves: 129P2/OlaHsd * C57BL/6	abnormal hematopoietic stem cell morphology	J:148955
	decreased erythroid progenitor cell number	J:148955
	decreased hematopoietic stem cell number	J:148955
Kat6atm1.1Glac/Kat6atm1.1Glac involves: 129P2/OlaHsd * C57BL/6	abnormal B cell differentiation	J:148955
	abnormal hematopoietic stem cell morphology	J:148955
	decreased body weight	J:148955
	decreased common myeloid progenitor cell number	J:148955
	decreased hematopoietic stem cell number	J:148955
	decreased immature B cell number	J:148955
	decreased pre-B cell number	J:148955
	decreased pro-B cell number	J:148955
	decreased spleen weight	J:148955
	decreased thymus weight	J:148955
	premature death	J:148955
	spleen hypoplasia	J:148955
	thymus hypoplasia	J:148955
Kat6atm1Avo/Kat6a+ either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6)	reduced fertility	J:108453
Kat6atm1Avo/Kat6a+ involves: 129 * BALB/c * FVB/N	abnormal definitive hematopoiesis	J:108453
	abnormal response/metabolism to endogenous compounds	J:188772
	cleft secondary palate	J:188772
	interrupted aortic arch, type b	J:188772
	normal reproductive system phenotype	J:108453
	retroesophageal right subclavian artery	J:188772
	small thymus	J:188772
	transposition of great arteries	J:188772
Kat6atm1Avo/Kat6atm1Avo either: 129 or (involves: 129 * C57BL/6) or (129 * BALB/c * FVB/N)	abnormal cervical atlas morphology	J:155755
	abnormal cervical vertebrae morphology	J:155755
	abnormal innervation	J:155755
	decreased thoracic vertebrae number	J:155755
	hunched posture	J:155755
	thoracic vertebral transformation	J:155755
Kat6atm1Avo/Kat6atm1Avo involves: 129/Sv * BALB/c * FVB/N	abnormal aortic arch morphology	J:108453, J:188772
	abnormal craniofacial morphology	J:108453
	abnormal erythropoiesis	J:108453
	abnormal fourth pharyngeal arch artery morphology	J:188772
	abnormal heart morphology	J:188772
	abnormal hematopoietic stem cell morphology	J:188772
	abnormal pulmonary trunk morphology	J:188772
	abnormal thymus development	J:108453
	abnormal vertebrae morphology	J:188772
	absent spleen	J:108453
	athymia	J:188772
	atrial septal defect	J:188772
	atrioventricular septal defect	J:188772
	cleft palate	J:108453, J:188772
	common ventricle	J:188772
	cyanosis	J:108453
	decreased bone marrow cell number	J:108453
	decreased double-negative T cell number	J:108453
	decreased hematopoietic stem cell number	J:108453
	hemorrhage	J:108453
	increased nucleated erythrocyte cell number	J:108453
	interrupted aortic arch, type b	J:188772
	micrognathia	J:188772
	neonatal lethality, complete penetrance	J:188772
	overriding aortic valve	J:188772
	perinatal lethality, complete penetrance	J:108453
	retroesophageal right subclavian artery	J:188772
	small thymus	J:108453, J:188772
	thymus hypoplasia	J:108453
	ventricular septal defect	J:188772
Kat6atm1b(EUCOMM)Wtsi/Kat6atm1b(EUCOMM)Wtsi involves: C57BL/6J * C57BL/6N	abnormal vascular development	J:222304
	decreased fetal size	J:222304
	lethality throughout fetal growth and development	J:222304
Kat6atm1c(EUCOMM)Wtsi/Kat6atm1c(EUCOMM)Wtsi Emx1tm1(cre)Krj/Emx1+ involves: 129S2/SvPas * C57BL/6J * C57BL/6N * CD-1	no abnormal phenotype detected	J:224155
Kat6atm1Iki/Kat6atm1Iki Not Specified	abnormal erythropoiesis	J:108699
	abnormal myelopoiesis	J:108699
	abnormal tail morphology	J:108699
	absent common myeloid progenitor cells	J:108699
	decreased B cell number	J:108699
	decreased hematopoietic stem cell number	J:108699
	hemorrhage	J:108699
	lethality throughout fetal growth and development, complete penetrance	J:108699
	liver hypoplasia	J:108699
	pallor	J:108699
	skin edema	J:108699
	small liver	J:108699
Kat6atm2.2Avo/Kat6a+ involves: BALB/c * FVB	abnormal craniofacial morphology	J:188772
	abnormal heart morphology	J:188772
	retroesophageal right subclavian artery	J:188772
	ventricular septal defect	J:188772
Kat6atm2.2Avo/Kat6atm2.2Avo either: 129 or (involves: 129 * C57BL/6) or (129 * BALB/c * FVB/N)	abnormal chromosome morphology	J:155755
Kat6atm2.2Avo/Kat6atm2.2Avo involves: BALB/c * FVB	abnormal hematopoietic stem cell morphology	J:188772
	lethality throughout fetal growth and development, complete penetrance	J:188772